Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo

K. Schuster, J. Zheng, A. A. Arbini, Chengcheng Zhang, Pier P Scaglioni

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Selective targeting of the mTORC1/2 protein kinase complexes leads to antileukemic effects in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences